LELA ALLEN: Open Payments
NPI 1104024777 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 31 payments from 19 companies in 2025. Trend: 2023 $1,660 · 2024 $1,108 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $97 |
| UCB, Inc. | 3 | $68 |
| Corcept Therapeutics | 3 | $61 |
| Amneal Pharmaceuticals LLC | 4 | $61 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
| Radius Health, Inc. | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
Products named: EVENITY, Bimzelx, Korlym, UNITHROID, Yorvipath, LUPKYNIS, Tymlos, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across GA — which companies pay providers there.
